Fortis Healthcare Ltd. (Fortis), India’s leading healthcare delivery Company, today, announced its consolidated results for the quarter ended June 30, 2016 (Q1FY17).
The Board of Directors at its meeting held today, provided an in-principle approval to demerge the company’s diagnostic business which includes operations of SRL Limited. The Board has formed a Restructuring Committee to detail the nuances of the demerger structure, including valuation, share entitlement ratio and other incidental matters and to present the same before the Board on August 19, 2016 for final approval.
India Business - Key Financial Highlights for the quarter (Q1FY17)
Reported Group Financial Highlights for Q1FY17
The reported results for the quarter are not comparable with the corresponding previous period due to progressive divestments of the Company’s international businesses.
For further details please contact:
Ajey Maharaj
Fortis Healthcare Ltd
9871798573
Anurag Kalra / Gaurav Chugh
Fortis Healthcare Ltd
9810109253 / 9958588900
Read Complete Press Release on below link:
Download PDF - English